-
公开(公告)号:US20190076500A1
公开(公告)日:2019-03-14
申请号:US16127509
申请日:2018-09-11
Applicant: Novartis AG
Inventor: Michael Badman , Clifford Brass , Bryan Laffitte
IPC: A61K38/06 , A61K31/192 , A61K31/428 , A61K31/4162 , A61P1/16
Abstract: The invention provides pharmaceutical compositions comprising a farnesoid X receptor (FXR) agonist or caspase inhibitor and another therapeutic agent, e.g. PPAR-delta agonist in particular for treating or preventing liver diseases or disorders.